title: Cell-mediated autoimmunity in paraneoplastic neurological syndromes with anti-Hu antibodies.
abstract: Paraneoplastic encephalomyelitis or subacute sensory neuronopathy associated with small-cell lung cancer (SCLC) and high titers of anti-HuD antibodies, also called the "anti-Hu syndrome," is believed to result from an immune response triggered by tumor antigens and misdirected to the neurons. To further assess the issue of cell-mediated immunity in this disease, the peripheral blood lymphocyte surface phenotype was studied in 15 patients suffering from the anti-Hu syndrome (seropositive group) and in two control groups consisting of 12 seronegative SCLC patients without neurological syndrome and 15 healthy volunteers. In addition, the recombinant human HuD protein was used to stimulate in vitro peripheral blood mononuclear cells of 10 seropositive patients and of 10 patients from each control group. Phenotypic analysis of the peripheral blood lymphocytes revealed a significant increase of the memory helper (CD45RO+CD4+) T cells in the seropositive group in comparison with the two control groups. Antigen-specific proliferation of peripheral blood mononuclear cells, measured by [3H]thymidine uptake after HuD antigen stimulation, was much higher in the seropositive group than in the two control groups, and phenotypic analysis of proliferating cells revealed a significant expansion of the CD45RO subpopulation of T cells in the seropositive group. Furthermore, after HuD stimulation, a significant increase of the interferon-gamma/interleukin-4 ratio was found in culture supernatants of the seropositive group compared with seronegative SCLC patients and normal controls. Taken together, these results indicate that HuD protein is an antigenic target for autoreactive CD4+ T cells, presumably of the Th1 subtype, which could therefore be directly involved in cell-mediated injury of the nervous system as well as in antitumoral immunity.
authors.affiliation: Department of Neurology and INSERM U 495, Groupe Haspitalier Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, France.
authors.forename: B
authors.initials: B
authors.lastname: Benyahia
authors.forename: R
authors.initials: R
authors.lastname: Liblau
authors.forename: H
authors.initials: H
authors.lastname: Merle-Béral
authors.forename: J M
authors.initials: JM
authors.lastname: Tourani
authors.forename: J
authors.initials: J
authors.lastname: Dalmau
authors.forename: J Y
authors.initials: JY
authors.lastname: Delattre
mesh_terms: D001323:Autoantibodies / Q000276:immunology*; D015551:Autoimmunity / Q000276:immunology*; D051959:ELAV Proteins; D000067779:ELAV-Like Protein 4; D006801:Humans; D008213:Lymphocyte Activation / Q000276:immunology; D009419:Nerve Tissue Proteins; D010257:Paraneoplastic Syndromes / Q000276:immunology*; D016601:RNA-Binding Proteins / Q000276:immunology*